We believe that cardiovascular health should be accessible to everyone, everywhere.
Reducing the gap in arrhythmia diagnosis worldwide
In the world, 100 million tests are not carried out every year. 1, 2, 3
In Brazil: 20 million people have arrhythmias, only 2 million undergo Holter tests.12, 13, 14
Quoretech exists to eliminate delays, inaccessibility and inaccuracies in arrhythmia diagnosis, saving lives and improving the quality of care for millions of people around the world.
How can we transform the cardiovascular diagnosis journey?
Advanced and accessible technology at the point of service.
A complete platform supported by a performance-optimized algorithm.
Scalable business model, no initial investment required
Greater patient satisfaction: NPS of 95.9.
Our beliefs
People first
We prioritize patients, partners and team members in all decisions and actions.
Think big - think bold
Our aim is to achieve a transformative impact by challenging traditional models with innovative solutions.
Endless improvement
We adopt a mindset of continuous learning, iteration and excellence in all our operations.
Fast learning
We adapt quickly, learning from data, feedback, successes and failures.
Important moments
We recognize and honor milestones and achievements, reinforcing a positive and motivated culture.
Simplicity
We design products, processes and communications to be intuitive, efficient and easy to use, avoiding unnecessary complexity.
References
1. Worldometer, Current World Population, Available at: [https://www.worldometers.info/world-population/], Accessed on: April 25, 2025
2. Karamitanha F., et al, Difference Between Various Countries in Mortality and Incidence Rate of the Atrial Fibrillation Based on Human Development Index in Worldwide: Data From Global Burden of Disease 2010-2019, Current Problems in Cardiology Volume 48, Issue 1, January 2023
3. Van Gelder I. C, et al, 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS), European Heart Journal (2024) 00, 1-101, https://doi.org/10.1093/eurheartj/ehae176 and Risks, 1990-2022100000.
4.Known S., et al, Comparison Between the 24-hour Holter Test and 72-hour Single-Lead Electrocardiogram Monitoring With an Adhesive Patch-Type Device for Atrial Fibrillation Detection: Prospective Cohort Study, J Med Internet Res. 2022 May; 24(5): e37970. Published online May 9, 2022. doi: 10.2196/37970: 10.2196/37970.
5. Kim J. Y., et al, The efficacy of detecting arrhythmia is higher with 7-day continuous electrocardiographic patch monitoring than with 24-h Holter monitoring, Journal of Arrhythmia, Received: January 3, 2023 | Revised: April 13, 2023 | Accepted: April 20, 2023, DOI: 10.1002/joa3.12865.
6. Cadastro Nacional de Estabelecimentos de Saúde (CNES), Consulta Estabelecimentos, Nome com "COR" ou "CARDIO", mediana dos estabelecimentos, Available at: [https://cnes.datasus.gov.br/], accessed on 02May2025.
7. Hospital Israelita Albert Einstein, A Comparative study of an innovative 3-lead wireless water resistant Holter system and a conventional Holter system, Available at: [https://clinicaltrials.gov/study/NCT04723355?term=Quoretech&rank=1]; Accessed on: 25April2025
8. Data on file, Quoretech July/21
9. Yenikomshian M., et al, Cardiac arrhythmia detection outcomes among patients monitored with the Zio patch system: a systematic literature review, Curr Med Res Opin. 2019 Oct;35(10):1659-1670. doi: 10.1080/03007995.2019.1610370. Epub 2019 May 28.
10. Leclercq C., et al, Wearables, telemedicine and artificial intelligence in arrhythmias and heart failure: Proceedings of the Cardiovascular Roundtable of the European Society of Cardiology, EP Europace, Volume 24, Issue 9, September 2022, Pages 1372-1383, https://doi.org/10.1093/europace/euac05
11. ROL_ANS, Available at: [https://www.ans.gov.br/ROL-web/], Accessed on: 25April2025
12. SOBRAC, A vida de um portador de arrritmia cardíaca, Available at: [https://sobrac.org/publico-geral/sdrfvesfvs/], Accessed on: April 25, 2025
13. ANS, TISS Data Panel, Procedures 2024, Available at: [https://app.powerbi.com/view?r=eyJrIjoiZGVjMDI2NjItNTUzMS00OWJkLTgwNjMtOTJmNTVlYzYwMTg0IiwidCI6IjlkYmE0ODBjLTRmYTctNDJmNC1iYmEzLTBmYjEzNzVmYmU1ZiJ9], Accessed on: April 25, 2025
14. DATASUS, AMBULATORY PRODUCTION OF THE SUS - BRAZIL - BY PLACE OF CARE, HOLTER, Available at: [http://tabnet.datasus.gov.br/cgi/tabcgi.exe?sia/cnv/qabr.def], Accessed on: 25April2025
The validated algorithmic models are intended to assist doctors by highlighting potential arrhythmic events. The results are designed for interpretation and confirmation by qualified healthcare professionals and do not replace medical judgment.
